PULSION Medical Systems SE (PUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, PULSION Medical Systems SE (PUS) has a cash flow conversion efficiency ratio of 0.160x as of December 2017. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.30 Million ≈ $3.86 Million USD) by net assets (€20.60 Million ≈ $24.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PULSION Medical Systems SE (PUS) balance sheet quality index to measure how much of total assets are equity-financed.
PULSION Medical Systems SE - Cash Flow Conversion Efficiency Trend (2003–2017)
This chart illustrates how PULSION Medical Systems SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of PULSION Medical Systems SE to evaluate the quality of earnings relative to operating cash generation.
PULSION Medical Systems SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PULSION Medical Systems SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Spurcorp
JSE:SUR
|
0.257x |
|
Orge Enerji Elektrik Taahhut AS
IS:ORGE
|
-0.032x |
|
Sierra Metals Inc.
TO:SMT
|
0.249x |
|
Wonder Electricals Limited
NSE:WEL
|
0.133x |
|
NP3 Fastigheter AB (publ)
ST:NP3-PREF
|
0.016x |
|
Honma Golf Limited
F:HF5
|
0.008x |
|
Terra Santa Propriedades Agrícolas S.A.
SA:LAND3
|
0.070x |
|
Creative Sensor Inc
TW:8249
|
0.036x |
Annual Cash Flow Conversion Efficiency for PULSION Medical Systems SE (2003–2017)
The table below shows the annual cash flow conversion efficiency of PULSION Medical Systems SE from 2003 to 2017. For the full company profile with market capitalisation and key ratios, see PUS market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2017-12-31 | €20.60 Million ≈ $24.08 Million |
€3.30 Million ≈ $3.86 Million |
0.160x | -58.51% |
| 2016-12-31 | €20.60 Million ≈ $24.08 Million |
€7.95 Million ≈ $9.30 Million |
0.386x | +2.01% |
| 2015-12-31 | €20.60 Million ≈ $24.08 Million |
€7.80 Million ≈ $9.11 Million |
0.378x | +17.18% |
| 2013-12-31 | €17.59 Million ≈ $20.56 Million |
€5.68 Million ≈ $6.64 Million |
0.323x | -14.55% |
| 2012-12-31 | €23.84 Million ≈ $27.87 Million |
€9.01 Million ≈ $10.53 Million |
0.378x | +19.36% |
| 2011-12-31 | €21.10 Million ≈ $24.66 Million |
€6.68 Million ≈ $7.81 Million |
0.317x | -19.62% |
| 2010-12-31 | €16.56 Million ≈ $19.36 Million |
€6.52 Million ≈ $7.63 Million |
0.394x | +68.19% |
| 2009-12-31 | €16.98 Million ≈ $19.85 Million |
€3.98 Million ≈ $4.65 Million |
0.234x | +285.75% |
| 2008-12-31 | €16.24 Million ≈ $18.99 Million |
€986.00K ≈ $1.15 Million |
0.061x | -77.22% |
| 2007-12-31 | €17.05 Million ≈ $19.94 Million |
€4.55 Million ≈ $5.31 Million |
0.267x | +21.43% |
| 2006-12-31 | €14.63 Million ≈ $17.10 Million |
€3.21 Million ≈ $3.75 Million |
0.220x | -24.20% |
| 2005-12-31 | €11.25 Million ≈ $13.16 Million |
€3.26 Million ≈ $3.81 Million |
0.290x | +20.71% |
| 2004-12-31 | €9.20 Million ≈ $10.76 Million |
€2.21 Million ≈ $2.58 Million |
0.240x | +139.46% |
| 2003-12-31 | €8.31 Million ≈ $9.72 Million |
€833.00K ≈ $973.86K |
0.100x | -- |
About PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more